{"id":"W4395465591","doi":"10.1097/qai.0000000000003434","title":"Brief Report: HIV-1 Resistance Analysis of Participants With HIV-1 and Hepatitis B Initiating Therapy With Bictegravir/Emtricitabine/Tenofovir Alafenamide or Dolutegravir Plus Emtricitabine/Tenofovir Disoproxil Fumarate: A Subanalysis of ALLIANCE Data","year":2024,"lang":"en","type":"article","venue":"JAIDS Journal of Acquired Immune Deficiency Syndromes","topic":"HIV/AIDS drug development and treatment","field":"Medicine","cited_by":3,"is_retracted":false,"has_abstract":true,"ca_institutions":"Tellabs (Canada)","funders":"ViiV Healthcare; Gilead Sciences; University of Warwick; GlaxoSmithKline","keywords":"Emtricitabine; Dolutegravir; Tenofovir alafenamide; Virology; Medicine; Tenofovir; Human immunodeficiency virus (HIV); Viral load; Antiretroviral therapy","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002855309,0.000359809,0.0002937132,0.0007862209,0.0004157271,0.0004836787,0.0004195247,0.0004429023,0.008275616],"category_scores_gemma":[0.006786646,0.0001748759,0.0004942017,0.00078614,0.0001167024,0.0003040191,0.0003998844,0.0003896094,0.001298893],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003274004,"about_ca_system_score_gemma":0.0008721486,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002370428,"about_ca_topic_score_gemma":0.002110902,"domain_scores_codex":[0.9987028,0.0004380939,0.0002371596,0.0001925101,0.0003457784,0.00008369785],"domain_scores_gemma":[0.9932079,0.001526634,0.002479619,0.0004861216,0.001529723,0.0007700388],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.007196039,0.0007429958,0.8670881,0.001173551,0.0007043646,0.000793775,0.0005569039,0.0001426316,0.004118306,0.00008979852,0.06295828,0.05443526],"study_design_scores_gemma":[0.0008688739,0.005131976,0.932641,0.0001692645,0.0005041888,0.001804087,0.0004654647,0.00034887,0.002611678,0.0001309437,0.05527984,0.00004367125],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8664499,0.002262644,0.001533666,0.002936181,0.001304185,0.002820611,0.1129424,0.0002273267,0.009522988],"genre_scores_gemma":[0.9271842,0.001386776,0.00247812,0.002238771,0.001257553,0.002358886,0.053669,0.00007852521,0.009348098],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008275616,"threshold_uncertainty_score":0.02768475,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04077285838012889,"score_gpt":0.3002681926624679,"score_spread":0.259495334282339,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}